New sunscreen aims to stop skin spots before they turn dangerous

NCT ID NCT07335003

First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 23 times

Summary

This study tests whether a new sunscreen, Anthelios Fluide 100 KA+ UVMune 400, can prevent actinic keratosis (AK) — rough, scaly spots that can turn into skin cancer — in people aged 60 and older who already have many of these spots. Participants will be randomly assigned to use the sunscreen or follow standard sun protection for a period, and researchers will count how many new AK spots appear. The goal is to see if this sunscreen offers better protection against these pre-cancerous lesions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital

    RECRUITING

    Camperdown, New South Wales, 2050, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.